{"ok":true,"nota":{"id":"cdcfb34f2ed82479","slug":"un-programa-de-farmacia-personalizado-mejoro-que-personas-con-diabetes-cdcfb3","titulo":"Un programa de farmacia personalizado mejoró que personas con diabetes tomen sus pastillas como corresponde","resumen":"Un ensayo aleatorizado con personas con diabetes tipo 2 que no seguían bien su medicación oral comparó un programa personalizado en farmacias comunitarias con la atención habitual, durante seis meses. Se realizó en los Países Bajos y el Reino Unido.","fuente":"medrxiv","fuenteNombre":"medRxiv · preprints","color":"#1f7a4d","autor":"Langendoen-Gort, M., Remmelzwaal, S., Rutters, F., Al-Jabr, H., De Wit, M., Bhattacharya, D., Hugtenburg, J., Farmer, A.","url":"https://www.medrxiv.org/content/10.64898/2026.10.28.26366703v1?rss=1","imagen":"/hoy/portada/cdcfb34f2ed82479","tema":"salud","subtemas":["adherencia a medicamentos","diabetes tipo 2","farmacias comunitarias","hipertension","ensayo aleatorizado"],"entidades":["Países Bajos","Reino Unido"],"formato":"dato","entretenimiento":false,"pubTs":"2026-10-29T00:00:00.000Z","indexTs":"2026-10-30T00:18:54.680Z","hash":"a75e3d8d00825b3803a4b27137ca7c3fc60b35b7ffe21e0c5ef67707124e0908","tsa":{"time":"Oct 30 00:19:41 2026 GMT","provider":"freetsa.org","sobre":"sello"},"stats":{"views":0,"likes":0,"clicks":0,"dwell":0},"tipo":"normal","registro":"hallazgo","porQueImporta":"Muchas personas con diabetes o presión alta dejan de tomar sus pastillas sin avisar, y eso aumenta el riesgo de complicaciones a largo plazo. El estudio muestra que el farmacéutico, con seguimiento personalizado, puede ser una pieza clave para corregir eso sin esperar más consultas médicas. Como es un ensayo controlado con seis meses de seguimiento, da una señal sólida, aunque todavía falta saber si el efecto se mantiene después de terminado el programa.","quienFirma":"medRxiv · preprints","confianza":"revisado","consulta":null},"sello":{"hash":"a75e3d8d00825b3803a4b27137ca7c3fc60b35b7ffe21e0c5ef67707124e0908","sello":"f9ef7a5a7358f98da9cb1e9dee5176a32408c2b362870d3adc6535aa44b3d3a5","beacon":{"drand":{"cadena":"8990e7a9aaed2ffed73dbd7092123d6f289930540d7651336225dc172e51b2ce","ronda":6596285,"aleatorio":"c081b28c47de1b3ebaff2ab6fadd94a4e1d5df8956cce1796159e8f3a3c84477","tiempo":"2026-10-30T00:19:30.000Z"},"nist":{"cadena":2,"pulso":2005076,"salida":"D1D471A81853AED712E452A7D73F82257D9E5310F62C5D5691DE99C64EC2110FF870FD06ACCC0EFE8D43CE6737ABC2C8D9860CE82BDD7542A5890EDDB8765434","tiempo":"2026-10-30T00:18:00.000Z"},"noAntes":"2026-10-30T00:19:30.000Z"},"verificacion":{"drand":true,"nist":true},"tsa":{"time":"Oct 30 00:19:41 2026 GMT","provider":"freetsa.org","sobre":"sello"},"original":{"titulo":"Effectiveness of a pharmacy-led personalised intervention program aimed at improving adherence to oral diabetes and/or hypertension medication in people with type 2 diabetes","descripcion":"Aims/hypothesis: To evaluate the effectiveness of a personalised intervention program aimed at improving medication adherence in people with type 2 diabetes who are non-adherent to oral diabetes and/or hypertension medication, compared to usual care including access to a diabetes website, after a six-month follow-up. Methods: Parallel-group randomised controlled trial with six-month follow-up conducted in community pharmacies in the Netherlands and United Kingdom. People with type 2 diabetes, 35-75 years and non-adherent to oral diabetes and/or hypertension medication were recruited. The intervention group received the personalised intervention program and the control group received usual ca","pubDate":"2026-10-29","url":"https://www.medrxiv.org/content/10.64898/2026.10.28.26366703v1?rss=1"},"indexado":"2026-10-30T00:18:54.680Z"}}